Sun Pharma to Acquire Organon in Transformative $11.75 Billion Deal Focused on Women’s Health
Sun Pharma has announced a landmark definitive agreement to acquire Organon in an all-cash transaction valued at approximately $11.75 billion, marking one of the...
Novartis Receives European Commission Approval for Rhapsido®, the First Oral Targeted Therapy for Chronic Spontaneous Urticaria
Novartis has officially received European Commission (EC) approval for Rhapsido® (remibrutinib), marking a historic shift in the management of chronic spontaneous urticaria (CSU). Rhapsido...
A Global Pediatric Milestone: WHO Pre qualifies First Malaria Treatment for Newborns and Young Infants
In a landmark step for global child health, the World Health Organization (WHO) has prequalified the world’s first malaria treatment specifically designed for newborns...
Cipla Secures U.S. FDA Approval for First AB-Rated Generic Therapeutic Equivalent to Ventolin® HFA
The United States Food and Drug Administration (USFDA) has granted final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol,...
IPC Forges Strategic Alliances with PMBI and NIPER Hajipur to Redefine India’s Drug Safety and Pharma Research Landscape
Under the visionary leadership of Hon’ble Prime Minister Shri Narendra Modi, India continues to fortify its commitment to accessible, high-quality healthcare. In a landmark...
AbbVie Moves Toward “Fast-Acting” Botox Alternative: FDA Requests Final Manufacturing Details for 24-Hour Frown Line Treatment
AbbVie is set to rewrite the timeline of aesthetic medicine, as it received the receipt of a Complete Response Letter (CRL) from the...